Gilead names Daniel O’Day as Chairman and CEO

Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...

December 11, 2018 | Tuesday | News
Trianni, MacroGenics enter into a license agreement

Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...

December 8, 2018 | Saturday | News
Merck teams up with Cyclica for AI-augmented screening Platform

Merck, a leading science and technology company has entered into a licensing agreement with Cyclica Inc. for the use of ...

December 7, 2018 | Friday | News
Impel NeuroPharma Closes $67.5M Series D Financing

Seattle-based biotechnology company, Impel NeuroPharma has announced that it has completed a Series D financing totaling...

December 7, 2018 | Friday | News
Diamyd Medical raises SEK 58.4 million through redemption of warrants

Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...

December 6, 2018 | Thursday | News
Philips Recognized by Frost & Sullivan for Its PMAS system

Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...

December 6, 2018 | Thursday | News
Phagomed wins Austrian entrepreneurship award

Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...

December 5, 2018 | Wednesday | News
ResMed to acquire Propeller Health for $225M

Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...

December 5, 2018 | Wednesday | News
Domain Therapeutics collaborates with Boehringer Ingelheim

Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...

December 5, 2018 | Wednesday | News
argenx collaborates with Cilag GmbH International

argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...

December 3, 2018 | Monday | News
Editas Medicine announces pre-clinical data for treatment of Sickle Cell Diseases

Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome e...

December 3, 2018 | Monday | News
Auris Health announces $220 M growth financing

Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...

December 3, 2018 | Monday | News
Biocartis, AstraZeneca aim faster lung cancer biomarker results

Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...

December 3, 2018 | Monday | News
FDA approves first treatment developed by Catalyst Pharma for LEMS

The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...

December 1, 2018 | Saturday | News
Roche buys Jecure Therapeutics

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...

November 29, 2018 | Thursday | News
GE Healthcare to open biotech manufacturing centre in UK

GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...

November 28, 2018 | Wednesday | News
Incyte appoints new CSO

Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...

November 28, 2018 | Wednesday | News
Roivant launches Aruvant Sciences

US based pharma company Roivant Sciences and Cincinnati Children’s Hospital Medical centre has announced...

November 28, 2018 | Wednesday | News